CXCL12 and breast carcinoma: Additionally, the anti-migratory effects of violacein on cancer cells demonstrated in the present study are further supported by a recent study by Platt et al (36), which showed that violacein inhibited the secretion of the pro-cell migratory inflammatory chemokine CXCL12 in breast cancer cells.